Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement
Open accessThe DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Our objective was to evaluate the published literature and reach a consensus on the treatment of patients with ACTH-dependent Cushing's syndrome, because there is no recent consensus on the management of this rare disorder. PARTICIPANTS: Thirty-two leading endocrinologists, clinicians, and neurosurgeons with specific expertise in the management of ACTH-dependent Cushing's syndrome representing nine countries were chosen to address 1) criteria for cure and remission of this disorder, 2) surgical treatment of Cushing's disease, 3) therapeutic options in the event of persistent disease after transsphenoidal surgery, 4) medical therapy of Cushing's disease, and 5) management of ectopic ACTH syndrome, Nelson's syndrome, and special patient populations. EVIDENCE: Participants presented published scientific data, which formed the basis of the recommendations. Opinion shared by a majority of experts was used where strong evidence was lacking. CONSENSUS PROCESS: Participants met for 2 d, during which there were four chaired sessions of presentations, followed by general discussion where a consensus was reached. The consensus statement was prepared by a steering committee and was then reviewed by all authors, with suggestions incorporated if agreed upon by the majority. CONCLUSIONS: ACTH-dependent Cushing's syndrome is a heterogeneous disorder requiring a multidisciplinary and individualized approach to patient management. Generally, the treatment of choice for ACTH-dependent Cushing's syndrome is curative surgery with selective pituitary or ectopic corticotroph tumor resection. Second-line treatments include more radical surgery, radiation therapy (for Cushing's disease), medical therapy, and bilateral adrenalectomy. Because of the significant morbidity of Cushing's syndrome, early diagnosis and prompt therapy are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As with Cushing’s disease, it may be helpful to use a cortisol synthesis blocking drug while waiting for definitive treatment (18) and in cases where definitive treatment is not possible.”
From ACTH Antagonists (2016) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Once a diagnosis is conclusively made, the optimal treatment is surgical removal of the tumor – ideally preserving the remaining pituitary function.”
From ACTH Antagonists (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362 · cited 3×
“excess cortisol secretion by unilateral adrenocortical tumors or by bilateral adrenal hyperplasia or dysplasia (1).”
BackgroundInfluentialSelf-citationValvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease
Zanettini, R., Antonini, A., Gatto, G., Gentile, R., Tesei, S., & Pezzoli, G. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa054830 · Cited by 884 · cited 1×
“However, more data are required not only for efficacy but also to address the long-term safety of cabergoline in these patients (84, 85).”
BackgroundThe Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
Self-citationDopamine Agonists and the Risk of Cardiac-Valve Regurgitation
Schade, R., Andersohn, F., Suissa, S., Haverkamp, W., & Garbe, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062222 · Cited by 718
Ilias, I., Torpy, D. J., Pacak, K., Mullen, N., Wesley, R. A., & Nieman, L. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2527 · Cited by 713
Self-citationBruns, C., Lewis, I., Briner, U., Meno-Tetang, G., & Weckbecker, G. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460707 · Cited by 692
Isidori, A. M., Kaltsas, G. A., Pozza, C., Frajese, V., Newell-Price, J., Reznek, R. H., Jenkins, P. J., Monson, J. P., Grossman, A. B., & Besser, G. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1542 · Cited by 522
Self-citationThe hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment
Lindsay, J. R., & Nieman, L. K. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0025 · Cited by 449 · cited 1×
“Detection of Cushing’s syndrome usually occurs late in gestation, and the diagnosis is complicated by the signs of normal pregnancy, such as central weight gain, facial plethora, and pigmentation (101) and the normal physiological changes in the maternal HPA axis.”
BackgroundSelf-citationPosterior retroperitoneoscopic adrenalectomy–results of 560 procedures in 520 patients
Walz, M. K., Alesina, P. F., Wenger, F. A., Deligiannis, A., Szuczik, E., Petersenn, S., Ommer, A., Groeben, H., Peitgen, K., Janssen, O. E., et al. (2006) · Surgery · doi:10.1016/j.surg.2006.07.039 · Cited by 425
Self-citationRisk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.
Brada, M., Ford, D., Ashley, S., Bliss, J. M., Crowley, S., Mason, M., Rajan, B., & Traish, D. (1992) · BMJ · doi:10.1136/bmj.304.6838.1343 · Cited by 413 · cited 1×
“The risk of second tumor formation after pituitary radiation is considered to be in the range of 1–2% (39), but this may not be due to the radiotherapy per se.”
Background
Research works printed but not linked: 1
- 52. Sonino N, Boscaro M, Ambroso G, Merola G, Mantero F 1986 Prolonged - treatment of Cushing's disease with metyrapone and aminoglutethimide. IRCS Med Sci 14:485-486
Cited by
Items 701–800 of 863
Cardiopatías de origen endocrino: una etiología frecuentemente olvidada
Duque-González, L., Ruíz, L. M., Torres-Grajales, J. L., & Duque-Ramírez, M. (2020) · Medicina y Laboratorio · doi:10.36384/01232576.298 · Cited by 4
“Si se sospecha adenoma hipofisario, se puede realizar imagen por resonancia magnética de silla turca, y, finalmente, si hay sospecha de producción ectópica de ACTH, se puede hacer tomografía de tórax y abdomen, resonancia de abdomen o gammagrafía con radiofármaco y receptores de somatostatina (octreoscan) [21,28].”
BackgroundCushing's syndrome and acromegaly based on picoadenoma of the pituitary gland
Ságová, I., Kantárová, D., Pávai, D., Dragula, M., Vaňuga, A., & Vaňuga, P. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.040 · Cited by 1
Prognostic markers of remission of cushing's disease after transsphenoidal endoscopic adenomektomii.
Gussaova, N., Choi, W. A., Cherebillo, V. Y., Paltsev, A. A., Savello, A. V., Ryazanov, P. A., Mitrofanova, L. B., Солнцев, В. Н., & Grineva, E. N. (2018) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2017-95-12-1106-1111 · Cited by 1
COVID-19 Complicating Cushing Syndrome in a Nigerian Infant: A Case Report
Babatunde, O., Akinola, I., Okere, E., Ebili, L., Lawal, T. A., & Nwizu, E. (2021) · Annals of Health Research (The Journal of the Medical and Dental Consultants Association of Nigeria OOUTH Sagamu Nigeria) · doi:10.30442/ahr.0701-09-118 · Cited by 1
Pituitary adenomas: current principles of diagnosis and treatment
Astafyeva, L. I., Chernov, I. V., Chekhonin, I. V., Shults, E. I., Pronin, I., & Kalinin, P. L. (2021) · Russian journal of neurosurgery · doi:10.17650/1683-3295-2020-22-4-94-111 · Cited by 2
Esfahanian, F., Faiz, F., Zamani, M. M., & Hantoushzadeh, S. (2012) · Galen Medical Journal · doi:10.31661/gmj.v1i1.10 · Cited by 1
Pituitary Tumours in Pregnancy
Huang, W., & Molitch, M. E. (2022) · doi:10.1093/med/9780198870197.003.0175 · Cited by 1
Aktaş, G. E., Demir, S. S., & Sarıkaya, A. (2016) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2016.01.012 · Cited by 1
Jouanneau, E., Raverot, G., Trouillas, J., & Brassier, G. (2015) · EMC - Neurologia · doi:10.1016/s1634-7072(15)72180-x · Cited by 1
Clinical aspects of endocrinology: parathyroid and adrenal gland disorders
Otmani, W. E., & Bhatia, K. (2020) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2020.08.011 · Cited by 1
Wilson, G., Mooradian, A. D., Alexandraki, I., & Samrai, G. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1160-8.10035-1 · Cited by 1
Utz, A. L., & Klibanski, A. (2009) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000300022.92414.34 · Cited by 1
Self-citationEctopic ACTH syndrome complicated by hypercortisolism-associated urolithiasis. A case report
de León-Castorena, E., López-Sotomayor, D. M., Gaona-Garza, L. E., Treviño-Aguillón, M. A., & Mendoza, A. (2022) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2022.107449 · Cited by 1
Exploration biochimique de la corticosurrénale
Pilon, A., & Laudat, A. (2022) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(22)00246-5 · Cited by 1
Patel, G., Kahlon, S., & Ganesh, V. (2022) · Cureus · doi:10.7759/cureus.27904 · Cited by 1
“The treatment of choice is selective pituitary resection including medical management, radiation therapy, and bilateral adrenalectomy [4].”
BackgroundSaifi, S. A., Druce, I., Vickers, M. M., & Dennis, K. E. B. (2024) · Cureus · doi:10.7759/cureus.57852 · Cited by 1
Glucocorticoids - outcome in patients with glucocorticoid deficiency and Cushing's syndrome
Ragnarsson, Ó. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Karppinen, A. (2015) · Helda - University of Helsinki Institutional Repository · Cited by 2
Pituitary-directed medical treatment of Cushing’s disease
Arnaldi, G., Cardinaletti, M., Trementino, L., Tirabassi, G., & Boscaro, M. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.10 · Cited by 2
Self-citationERKRANKUNGEN DER ENDOKRINEN ORGANE UND DES STOFFWECHSELS
Jung, N., Mayet, W.-J., Mertens, P. R., Meyer, J. S., Müller, O.-A., Pfeifer, M., Schellinger, P. D., Weiss, N., & Wendtner, C.-M. (2020) · Elsevier eBooks · doi:10.1016/b978-3-437-06282-7.50015-2 · Cited by 1
Disorders of the Adrenal Gland
Desai, M. P., & Shah, N. S. (2012) · Springer eBooks · doi:10.1007/978-3-642-02202-9_384 · Cited by 1
Castinetti, F., & Brue, T. C. (2010) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(10)49745-8 · Cited by 1
Ipo- e iperpotassiemie nella pratica clinica: percorsi diagnostici e terapeutici
Giacchetti, G., Ronconi, V., Turchi, F., & Boscaro, M. (2009) · L Endocrinologo · doi:10.1007/bf03344640
Self-citationCostenaro, F. (2011) · Lume (Universidade Federal do Rio Grande do Sul) · Cited by 1
Psychosocial Aspects of Cushing’s Disease
Sonino, N. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_18
“Additional factors that may impair the quality of life and the speed of recovery involve maintenance medication and hormone replacement requirements, addressing any intervening pituitary hormone deficiency [59, 63, 64].”
Self-citationFaßnacht, M., & Kiess, W. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22107-1.50267-3
Guzzo, M. F. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-09022015-141630
Tritos, N. A., & Biller, B. M. K. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_6
“In addition, several agents inhibiting adrenal steroidogenesis, including ketoconazole, metyrapone, aminoglutethimide, or mitotane, have been shown to be of benefit in ameliorating hypercortisolism and have been used in CD patients failing pituitary surgery [46].”
BackgroundSelf-citationMedical Management of Pituitary Adenomas
Cappabianca, P., Prevedello, D. M., Angelis, M. D., Bornschein, A., Filho, L. F. S. D., Solari, D., Carrau, R. L., Esposito, F., de Lara, D., Cavallo, L. M., et al. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch23
Self-citationRomanholi, D. J. P. C. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2010.tde-21092010-095750
Adrenal Tumors in Older Persons
Carling, T., & Udelsman, R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-6999-6_36
Niwattisaiwong, S., Suh, J. H., Weil, R. J., & Hamrahian, A. H. (2014) · Endocrine Practice · doi:10.4158/ep14064.cr
Adrenocorticotrophin-dependent hypercortisolism: Imaging versus laboratory diagnosis
Tančić‐Gajić, M., Vujović, S., Ivović, M., Stojanovic, M. M., Marina, L., Barać, M., & Micić, D. (2012) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh1208500t
Comment on “Non-surgical treatment of hormone-secreting pituitary tumors”
Dobson, M., del Porto, L. A., & Maartens, N. F. (2010) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2010.01.014
Feelders, R. A. (2015) · Bijblijven · doi:10.1007/s12414-015-0031-3
Manejo de la enfermedad de Cushing persistente tras cirugía
Rodríguez, J. S. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-538-7.00010-1
Hipercortisolismo de origen suprarrenal: síndrome de Cushing
Blasco, F. Á., Buesa, M. A., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70398-0
Optimal management of Cushing syndrome
Edgar Gerardo Durán Durán-Pérez Edgar, G., Loza, O. T. M., Tobón, G. C., & Segovia-Palomo, A. (2012) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s25345
“73 Cortisol suppression is dose-dependent within a few hours with a dose of 4.5 g/day.”
InfluentialPapel da via lkaros-FGFR4 na evolução pós-cirúrgica dos pacientes com doença de Cushing
Brito, L. P. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2010.tde-25052010-172357
Do Inferior Petrosal Sinus Drainage Variations Affect the Sampling Lateralization Results?
Senol, S., Dönmez, H., Durak, A. C., & Kelestemur, F. (2013) · Erciyes Medical Journal · doi:10.5152/etd.2013.8319
Tratamiento médico de tumores hipofisarios
Becker, C. P. (2013) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(13)70218-9
Cushing's syndrome: a problem of excess cortisol
Peate, I., & Holmes, E. M. (2014) · British Journal of Healthcare Assistants · doi:10.12968/bjha.2014.8.2.80
Fatal outcome of persistent/recurrent Cushing's disease after pituitary surgery
Hsu, W., Chou, P., Lee, M., & Hsiao, P. (2014) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2014.06.003
Adrenal disease: cortex and medulla
Reilly, C. S. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511750441.006
Elshafie, O. T., Hashim, N., & Woodhouse, N. (2015) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2015/18691
Hypertonicity Regulation of Cytochrome P450 CYP3A
I-Chyang, A. C. (2012) · TSpace (University of Toronto)
MÁSTER EN INVESTIGACIÓN BIOMÉDICA TRASLACIONAL
Castano, J. P., Luque, R. M., & Gahete, M. D. (2013)
Adrenal-Directed Treatment Options for Cushing’s Disease
Young, W. F., & Thompson, G. B. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-449-4_11 · Cited by 1
TRABAJOS ESPECIALES MANEJO DE PACIENTES CON SÍNDROME DE CUSHING.
Lima-Martínez, M. M., Zerpa, J., Guerrero, Y., Rivera, J., & Vielma, M. (2013)
The Diagnostic Challenges in ACTH Dependent Cushing’s Disease
Xochitiotzi, E., Martínez, M., Arzola, T., Crespo, R., & Mehta, R. (2015) · International Journal of Medical and Pharmaceutical Case Reports · doi:10.9734/ijmpcr/2015/14571
Radiosurgery of the Sellar and Parasellar Region
Starke, R. M., Chen, C., Ding, D., & Sheehan, J. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-22855-6_7
Treatment of Pituitary Tumors: A Surgeon's Perspective
Buchfelder, M. (2014) · The Endocrine Society eBooks · doi:10.1210/mtp3.9781936704835.ch33
Self-citationZada, G., Lopes, M. B. S., Mukundan, S., & Laws, E. R. (2015) · Springer eBooks · doi:10.1007/978-3-319-22855-6_13
Yedinak, C. G., Brzana, J. A., McCartney, S., & Fleseriu, M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2059-4_3
Vlad, L. D., & Alzahrani, S. A. (2010) · Endocrine Practice · doi:10.4158/ep.16.6.1073
Vives, A. S. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Pituitary-dependent hyperadrenocorticism in a terrier dog: A case report
Rezaei, M., Rostami, S., Saberi, M., & Vosugh, D. (2016) · Journal of Coastal Life Medicine · doi:10.12980/jclm.4.2016j6-3
“The LDDST is more sensitive than ACTH stimulation test in confirming HAC, but it is not useful in the diagnosis of iatrogenic cases[4,13].”
BackgroundPituitary disease in pregnancy
Dworakowska, D., & Aylwin, S. J. B. (2012) · CRC Press eBooks · doi:10.1201/b14988-40
Hypercortisolism and Cushing's Syndrome☆
Kyritsi, E. M., Kourkouti, C., Chrousos, G. P., & Charmandari, E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99487-x · Cited by 1
Medical Management of Hormone-Secreting Pituitary Tumors
Mathioudakis, N. N., & Salvatori, R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6839-6.10017-6 · Cited by 1
Perioperative care of patients with endocrine disease
Hall, G., Hunter, J. M., & Cooper, M. S. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511750441.003
Fischer, A. S., Rizk, C. B., & Hsu, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139649520.014
Evaluation and Management of Cushing's
Feelders, R. A. (2015) · The Endocrine Society eBooks · doi:10.1210/mtp4.9781936704941.ch33
Recent trend of the pathophysiology and treatment of pituitary adenomas
Matsuno, A. (2014) · Institutional Repositories DataBase (IRDB) · doi:10.11452/neurooncology.21.1_29
McLaughlin, N., Kassam, A. B., Prevedello, D. M., & Kelly, D. F. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_13
Pituitary Tumours: A Brief Review
Senior Resident, D. R. I., & Mishra, H. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i1.13
“Surgery provides hormonal remission in 65-90% of cases of microadenomas, however there is 20% chance of recurrence of the disease at 10 years (18,19,20) .”
BackgroundPosttreatment Management of Cushing’s Disease
Prete, A., & Salvatori, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804340-0.00009-7 · Cited by 1
Crystallographic Characterization of Trilostane and Derivatives
Jopp, M., Becker, J., Lerch, M. M., Miska, A., Hausmann, H., Neiger, R., & Schindler, S. (2017) · ChemistrySelect · doi:10.1002/slct.201601976
Endoscopic Transsphenoidal Pituitary Surgery: Results and Complications
Singh, H., Essayed, W. I., Hussain, I., Yang, K. J. Z., Anand, V. K., & Schwartz, T. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-56691-7_15
Hypophysenadenome – nicht immer benigner Natur
Petersenn, S. (2017) · Der Onkologe · doi:10.1007/s00761-017-0319-2
Self-citationWilkinson, I. C. E., Savage, M. O., & Storr, H. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65338-2
Modern views on Cushing’s disease treatment
Kadzharyan, V. G., & Soloviuk, O. O. (2018) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2018.02.125354
Cushing Syndrome; Screening and Differential Diagnosis
Lacroix, A., & Nieman, L. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65857-9
Self-citationSickler, T. D. P. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-08052018-083923 · Cited by 2
Symptom Management in Lung Cancer
Nathani, N., & Arenberg, D. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-48565-4.00014-x
Cushing’s Disease: An Historical Perspective
Aron, D. C. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_1
Hyperkortisolismus – Cushing-Syndrom
Schulte, H. M., & Kamphausen, K. (2010) · Elsevier eBooks · doi:10.1016/b978-3-437-24680-7.10026-1
Castinetii, F. (2010) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2010.91
Cushing’s Syndrome and Disease
Moore, E. C., & Krishnamurthy, V. D. (2019) · Springer eBooks · doi:10.1007/978-3-319-98497-1_110
4 Functional and Nonfunctional Pituitary Adenomas
Chandra, A., & Aghi, M. K. (2019) · Springer eBooks · doi:10.1007/978-3-319-64379-3_4
Hauffa, B. P., Binder, G., Bonfig, W., Bettendorf, M., & Dörr, H. G. (2019) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-019-0697-1
A rare case of duodenal carcinoid presenting as ectopic Cushing’s syndrome
Pugalendhi, S., Dutta, T. K., Dhivya, & Yadav, K. (2019) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20192270
Paraneoplastic hypercortisolism : case report and review of available therapeutic options
Nguyen, A., Grigoriu, B. D., & Meert, A.-P. (2019) · Revue Medicale de Bruxelles · doi:10.30637/2019.18-069
A Stratified Approach for Cushing’s Syndrome Diagnosis
Chávez-Castillo, M., Rojas, J., Aguirre, M., Villalobos, M., Salazar, J. J., Bello, L., Áñez, R., Olivar, L. C., Calvo, M. C. C., Herazo-Beltrán, Y., et al. (2019) · Global Journal of Health Science · doi:10.5539/gjhs.v11n10p55
Kuritsyna, N., Lavrishcheva, Y. V., Cherebillo, V. Y., Борискина, О. Л., & Grineva, E. N. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-12-122-127
Pituitary Adenomas: Evaluation and Management From a Surgical Perspective
Maggio, W. W., & Shargorodsky, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-66195-9.00021-2
Gibbs, I. C., Tuniz, F., Laws, E. R., & Katznelson, L. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5897-7.00025-1
Nadezhdina, E. Y., Rebrova, O. Y., Antyukh, M. S., & Grigoriev, A. Y. (2019) · Vrach i informacionnye tehnologii · doi:10.37690/1811-0193-2019-4-65-71
Sindrome di Cushing in età pediatrica
Chioma, L., & Cappa, M. (2020) · L Endocrinologo · doi:10.1007/s40619-020-00788-y
Balentine, C. J., & Sippel, R. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-13662-2_35
Modern aspects of surgery for cushing’s disease
Abdali, A., Астафьева, Л. И., Trunin, Y. Y., Chernov, I. V., Sidneva, Y., Abdilatipov, A. A., & Kalinin, P. L. (2021) · Burdenko s Journal of Neurosurgery · doi:10.17116/neiro202185041111
Publication Landscape on Cushing's Disease: From the Past 40 Years to Future DirectionsPreprint
Luo, M., Du, K., Guo, X., Wang, Z., & Xing, B. (2021) · Research Square · doi:10.21203/rs.3.rs-834733/v1
8 Natural History and Management Options for Cushing’s Disease Cushing’s disease
(2021) · Thieme Medical Publishers eBooks · doi:10.1055/b-0041-184139
Surgical Management of Hypercortisolism from ACTH-Secreting Pituitary Adenomas
Morse, J. C., Thorp, B. D., & Kimple, A. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-87189-5_14
Aulinas, A., & Webb, S. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-90475-3_7
Morris, D. G., Grossman, A. B., & Nieman, L. K. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00015-0 · Cited by 3
Self-citation(2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32832eb365
Alexandraki, K., & Grossman, A. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_8 · Cited by 1
Self-citationCorticotropin-Dependent Cushing Syndrome: When Inferior Petrosal Sinus Sampling Is Not Needed
Young, W. F., & Bancos, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-79285-1.00056-x
Metadata
- Authors
- Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., Klibanski, A., Lacroix, A., Lindsay, J. R., Newell-Price, J., Nieman, L. K., Petersenn, S., Sonino, N., Stalla, G. K., Swearingen, B., Vance, M. L., Wass, J. A. H., & Boscaro, M.
- Affiliations
- Massachusetts General Hospital (US)
- St Bartholomew's Hospital (GB)
- Queen Elizabeth Hospital Birmingham (GB)
- Cedars-Sinai Medical Center (US)
- Hôpital Cochin (FR)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Naples Federico II (IT)
- Radboud University Nijmegen (NL)
- Erasmus MC (NL)
- Centre Hospitalier de l’Université de Montréal (CA)
- Altnagelvin Area Hospital (GB)
- University of Sheffield (GB)
- National Institutes of Health (US)
- University of Duisburg-Essen (DE)
- University of Padua (IT)
- Max Planck Institute of Psychiatry (DE)
- University of Virginia Health System (US)
- Churchill Hospital (GB)
- Marche Polytechnic University (IT)
- Corresponding author
- Boscaro, M.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-07-01
- Volume
- 93
- Issue
- 7
- Pages
- 2454-2462
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3214276
- OpenAlex
- W2147573461
- Cited by
- 853
- References
- 107
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 26 · 2023: 29 · 2022: 40 · 2021: 35 · 2020: 47 · 2019: 59 · 2018: 42 · 2017: 40 · 2016: 44 · 2015: 91 · 2014: 69 · 2013: 74 · 2012: 70
- FWCI
- 38.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Radboud Repository (Radboud University) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Max Planck Institute for Plasma Physics (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (Z01HD008833)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- ACTH-dependent Cushing's syndrome, Cushing's disease, ectopic ACTH syndrome, Nelson's syndrome, transsphenoidal surgery, pituitary tumor resection, radiotherapy, medical therapy, bilateral adrenalectomy, remission criteria, consensus statement
- MeSH terms
- ACTH Syndrome, Ectopic, Adrenal Insufficiency, Adrenalectomy, Adrenocorticotropic Hormone, Cushing Syndrome, Humans, Hypophysectomy, Metyrapone, Mitotane, Nelson Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.